| 摘要 |
Provided is a use in preventing and/or treating, by inhibiting a miR-96 function, hyperlipidemia, fatty liver, obesity, diabetes and symptoms similar to the symptoms of the above diseases. Also provided is a method for inhibiting the miR-96 function, comprising enabling a miR-96 inhibitor such as an antisense oligonucleotide to contact a target cell expressing miR-96. Also provided are an inhibitor inhibiting the miR-96 function, pharmaceutical composition and kit comprising the inhibitor, and use thereof in preventing and/or treating hyperlipidemia, fatty liver, obesity, diabetes and symptoms similar to the symptoms of the above diseases. |
